User:Mr. Ibrahem/Nateglinide
 | |
| Clinical data | |
|---|---|
| Trade names | Starlix |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a699057 |
| License data |
|
| Routes of administration | By mouth |
| Drug class | Meglitinide[1] |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | 98% |
| Elimination half-life | 1.5 hours |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C19H27NO3 |
| Molar mass | 317.429 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Nateglinide, sold under the brand name Starlix, is a medication used to treat type 2 diabetes.[2] It is used together with diet and exercise.[2] It is not a first line treatment, though may be added to metformin.[2][3] It is taken by mouth.[2]
Common side effects include dizziness, diarrhea, bronchitis, and low blood sugar.[2] Use is not recommended in those with significant liver problems.[3] Safety in pregnancy is not clear.[2] It belongs to the meglitinide class and works by stimulating the release of insulin.[1]
Nateglinide was approved for medical use in the United States in 2000 and Europe in 2001.[2][3] In the United States it costs about 30 USD per month as of 2021.[4] It is not available in the United Kingdom as of 2021.[1]
References[edit]
- ^ a b c d BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 742. ISBN 978-0857114105.
- ^ a b c d e f g h i "Nateglinide Monograph for Professionals". Drugs.com. Archived from the original on 2 September 2019. Retrieved 12 November 2021.
- ^ a b c "Starlix". Archived from the original on 12 November 2020. Retrieved 12 November 2021.
- ^ "Nateglinide Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 25 April 2020. Retrieved 12 November 2021.